|
NCBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.138200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.674200E-01 |
| Normal-vs-Stage2 |
3.699800E-01 |
| Normal-vs-Stage3 |
4.102300E-02 |
| Normal-vs-Stage4 |
1.698390E-02 |
| Stage1-vs-Stage2 |
8.296800E-01 |
| Stage1-vs-Stage3 |
2.728000E-01 |
| Stage1-vs-Stage4 |
1.703780E-01 |
| Stage2-vs-Stage3 |
3.664000E-01 |
| Stage2-vs-Stage4 |
2.901600E-01 |
| Stage3-vs-Stage4 |
8.353000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.333700E-02 |
| Normal-vs-AfricanAmerican |
5.432600E-01 |
| Normal-vs-Asian |
3.446000E-01 |
| Caucasian-vs-AfricanAmerican |
4.904800E-01 |
| Caucasian-vs-Asian |
4.378400E-01 |
| AfricanAmerican-vs-Asian |
9.141000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.828400E-02 |
| Normal-vs-Female |
1.281200E-01 |
| Male-vs-Female |
4.918400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.659240E-01 |
| Normal-vs-Age(41-60Yrs) |
8.372000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.092040E-01 |
| Normal-vs-Age(81-100Yrs) |
1.595960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.758200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.654600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.715000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.561400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.579400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.364000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.745400E-01 |
| Classical-VS-Follicular |
4.988200E-02 |
| Classical-VS-Other |
1.698640E-01 |
| Classical-VS-Normal |
3.715000E-01 |
| Tall-VS-Follicular |
6.388000E-01 |
| Tall-VS-Other |
4.018200E-01 |
| Tall-VS-Normal |
1.711760E-01 |
| Follicular-VS-Other |
6.332800E-01 |
| Follicular-VS-Normal |
2.629800E-02 |
| Other-VS-Normal |
8.271700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.896000E-02 |
| Normal-vs-N1 |
2.269800E-02 |
| N0-vs-N1 |
5.041800E-01 |
|
|
